Company Quick10K Filing
Lingerie Fighting Championships
10-Q 2019-09-30 Filed 2019-12-06
10-Q 2019-06-30 Filed 2019-11-29
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-09-11
10-Q 2018-03-31 Filed 2018-08-16
10-K 2017-12-31 Filed 2018-07-20
10-Q 2017-09-30 Filed 2018-03-05
10-Q 2017-06-30 Filed 2018-01-25
10-Q 2017-03-31 Filed 2017-07-06
10-K 2016-12-31 Filed 2017-06-01
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-20
10-K 2015-02-28 Filed 2015-06-03
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-09
10-Q 2014-05-31 Filed 2014-07-09
10-K 2014-02-28 Filed 2014-05-29
10-Q 2013-11-30 Filed 2014-01-17
10-Q 2013-08-31 Filed 2013-10-18
10-Q 2013-05-31 Filed 2013-07-16
10-K 2013-02-28 Filed 2013-06-13
10-Q 2012-11-30 Filed 2013-01-22
10-Q 2012-08-31 Filed 2012-10-19
10-Q 2012-05-31 Filed 2012-07-23
10-K 2012-02-29 Filed 2012-07-10
10-Q 2011-11-30 Filed 2012-01-23
10-Q 2011-08-31 Filed 2011-10-24
10-Q 2011-05-31 Filed 2011-07-19
10-K 2011-02-28 Filed 2011-06-15
10-Q 2010-11-30 Filed 2011-01-19
10-Q 2010-08-31 Filed 2010-10-19
10-Q 2010-05-31 Filed 2010-07-20
10-K 2010-02-28 Filed 2010-07-19
10-Q 2009-11-30 Filed 2010-02-12
8-K 2018-03-28
8-K 2018-03-05

Lingerie Fighting Championships Financials

BOTY Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
OWC Pharmaceutical Research (OWCP) 0 0% -0.2 362% 1,773 1,467 100 0 6,420 6,420 -1,465
Headhunter Group (HHR)
United States Short Oil Fund (DNO) 0 -0% 0.0 0 0 -600 0 -1,856 -1,856 -0
Immune Therapeutics (IMUN) 0 0.0 -29,381% 8 13,479 0 0 -2,476 -2,475 -6
Juniper Industrial (JIH)
PositiveID Corp (PSID)
Live Current Media (LIVC) 0 2.8 -26% 418 108 0 0 -110 -109 -306
Sun Pacific Holding (SNPW) 0 30% -17.5 -20% 6,669 10,975 260 77 -1,301 -315 5,510
Digatrade Financial (DIGAF) 0 0% 527 778 0 0 0 0 0
Lingerie Fighting Championships (BOTY) 0 -49% 0.2 -8,950,200% 23 -11 90 -10 -2
New Century Resources (NCRE) 0 0.0 0 205 0 0 -18 -17 -0
Arete Industries (ARET)
Renewable Energy Acquisition (REAC) 0 0.0 2,353,600% 0 0 -24 -22 -0
Sundial Growers (SNDL)
Energy Transfer Operating (ETP) 0 27% 5.8 4% 95,247,000 59,636,000 40,493,000 10,886,000 3,786,000 8,016,000 46,523,000
Blue Line Protection Group (BLPG) 0 40% 0.0 -189% 1,661 5,917 3,017 1,201 -3,138 -2,534 -19
ABCO Energy (ABCE) 0 38% 0.1 -173% 411 1,359 1,627 622 -713 -502 -28
Guided Therapeutics (GTHP) 0 332% 0.1 1,462% 404 16,413 28 93 5,908 6,835 439
Endonovo Therapeutics (ENDV) 0 73% -0.8 -301% 3,414 19,980 204 150 -10,268 -9,617 7,448
Dominovas Energy (DNRG)

Balance Sheet ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash251631661246136193247117262210225058321028101343102282
Accounts Receivable91402215
Inventory69
PP&E969285000
Assets583471388147586124613619324
Accounts Payable1377243
Long-Term Debt0
Liabilities2,0322,1942,3811,031183226118158177215247270842
Stockholders' Equity-220-106-154-115-180-228-267-6-3915311725-16-21-324-550-1,232-1,099-1,147-1,590-2,455-3,855-2,375-2,714-2,255-2,342-2,551-2,555
Income Statement ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue347339000000000019-1313155010602291219
Cost of Revenue18016180001430-110411154216198201201122
Gross Profit-1475721000-14-11-21-384-4-213-13-8-19061-9-3
R&D
SG&A3653683001259282864862644839940153181446788526497595742784957558245
Tax-0330000000000-000000000000
Net Income-691-313-282-125-184-86-48-62-64-48-39-9-32-21-44-92-41-5-203-256-1,339-63-48-579-867-1,4311,480-350-99290-102
Cash Flow ($'000)2011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-173-166-83-22-10-69-7-43-26-17-16-34-5-54-91-4-12-132-52-53-71-31-61-68-47-17-26
Cash Investing-9000003000000
Cash Financing186162150-250750100000516400-014480604508750801160